Patients with COVID-19 experience GI symptoms more frequently than noninfected controls

Hospitalized patients with COVID-19 had a “modest increased risk” for long-term gastrointestinal symptoms and irritable bowel syndrome compared with control patients, according to research published in Gut.“The data we collected show that those who have contracted COVID-19 experience gastrointestinal symptoms more frequently than those who have not been affected by it,” Giovanni Barbara, MD, study coordinator and professor of medical and surgical sciences at the University of Bologna in Italy, said in a related press release. “Given the vast spread of COVID-19Read More